Study of Clinical Profile and In-Hospital Outcomes of Patients Undergoing Percutaneous Transvenous Mitral Commissurotomy

Hassan  Shabeer

doi:10.54112/bcsrj.v6i5.1753

Authors

Hassan Shabeer Department of Interventional Cardiology, Armed Forces Institute Of Cardiology Rawalpindi, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i5.1753

Keywords:

Mitral stenosis, PTMC, rheumatic heart disease, echocardiography, mitral valve area

Abstract

Percutaneous Transvenous Mitral Commissurotomy (PTMC) is the preferred treatment for patients with symptomatic severe rheumatic mitral stenosis and favorable valve morphology. It replicates the physiological mechanism of surgical commissurotomy with less invasiveness. Objective: This study aimed to assess the clinical profile and in-hospital outcomes of patients undergoing PTMC at a tertiary cardiac care center. Methods: A prospective observational study was conducted at the Armed Forces Institute of Cardiology, Rawalpindi, from July 1 to December 31, 2023. A total of 96 patients with severe rheumatic mitral stenosis who met the eligibility criteria underwent PTMC. Baseline demographic, clinical, and echocardiographic data were recorded. Pre- and post-procedural mitral valve area (MVA), mean transmitral gradient, and pulmonary artery systolic pressure (PASP) were assessed. Procedural success and in-hospital complications were documented. Data were analyzed using SPSS version 26.0, with p-values <0.05 considered significant. Results: The mean age of the study population was 38.6 ± 10.4 years, with a female predominance (78.1%). Most patients (68.8%) presented in NYHA Class III. Mean MVA increased significantly from 0.89 ± 0.12 cm² to 1.85 ± 0.21 cm² (p < 0.001). Mean transmitral gradient reduced from 17.4 ± 4.3 mmHg to 6.9 ± 2.1 mmHg (p < 0.001), and PASP decreased from 58.6 ± 13.2 mmHg to 39.5 ± 9.4 mmHg (p < 0.001). Procedural success was achieved in 92.7% of patients. Mild and moderate mitral regurgitation developed in 18.8% and 4.2% of cases, respectively. Complications included cardiac tamponade (2.1%) and vascular hematoma (3.1%). There was no in-hospital mortality. Conclusion: PTMC is a safe and effective intervention for severe rheumatic mitral stenosis, resulting in significant hemodynamic and symptomatic improvement with minimal complications. Proper patient selection and procedural expertise are key to successful outcomes.

Downloads

Download data is not yet available.

References

Basnet K, Bhattarai SR, Shah S, Joshi A, Sah SK, Gami R, Khanal R. Rheumatic heart disease among patients with valvular heart disease admitted to the in-patient department of a tertiary care centre: a descriptive cross-sectional study. JNMA J Nepal Med Assoc. 2022;60(253):419–24. doi:10.31729/JNMA.7457.

Bailey CP. The surgical treatment of mitral stenosis (mitral commissurotomy). Dis Chest. 1949;15(4):377–93. doi:10.1378/CHEST.15.4.377.

Inoue K, Owaki T, Nakamura T, Kitamura F, Miyamoto N. Clinical application of transvenous mitral commissurotomy by a new balloon catheter. J Thorac Cardiovasc Surg. 1984;87(3):394–402. doi:10.1016/s0022-5223(19)37390-8.

Lock JE, Khalilullah M, Shrivastava S, Bahl V, Keane JF. Percutaneous catheter commissurotomy in rheumatic mitral stenosis. N Engl J Med. 1985;313(24):1515–8. doi:10.1056/NEJM198512123132405.

McKay RG, Lock JE, Keane JF, Safian RD, Aroesty JM, Grossman W. Percutaneous mitral valvuloplasty in an adult patient with calcific rheumatic mitral stenosis. J Am Coll Cardiol. 1986;7(6):1410–5. doi:10.1016/S0735-1097(86)80164-4.

Kaul UA, Singh S, Kalra GS, Nair M, Mohan JC, Nigam M, Arora R. Mitral regurgitation following percutaneous transvenous mitral commissurotomy: a single-center experience. J Heart Valve Dis. 2000;9(2):262–8.

Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP III, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease. J Am Coll Cardiol. 2021;77(4):e25–e197. doi:10.1016/j.jacc.2020.11.018.

Bhardwaj P, Chaudhury S, Aneja A, Jetley V, Walia TS, Mujawar S. Assessment of quality of life before and after successful percutaneous transvenous mitral commissurotomy in patients with severe mitral stenosis. Ind Psychiatr J. 2019;28(1):51–7. doi:10.4103/ipj.ipj_4_19.

Herrmann HC, Ramaswamy K, Isner JM, Feldman TE, Carroll JD, Pichard AD, et al. Factors influencing immediate results, complications, and short-term follow-up status after Inoue balloon mitral valvotomy: a North American multicenter study. Am Heart J. 1992;124(1):160–6. doi:10.1016/0002-8703(92)90935-o.

Salarifar M, Rezvanfard M, Sadeghian H, Safir-Mardanloo A, Shafii N. Mitral annular calcification predicts immediate results of percutaneous transvenous mitral commissurotomy. Cardiovasc Ultrasound. 2011;9:29. doi:10.1186/1476-7120-9-29.

Varma PK, Theodore S, Neema PK, Ramachandran P, Sivadasanpillai H, Nair KK, et al. Emergency surgery after percutaneous transmitral commissurotomy: operative versus echocardiographic findings, mechanisms of complications, and outcomes. J Thorac Cardiovasc Surg. 2005;130(3):772–6. doi:10.1016/j.jtcvs.2005.04.021.

Esteves CA, Munoz JS, Braga S, Andrade J, Meneghelo Z, Gomes N, et al. Immediate and long-term follow-up of percutaneous balloon mitral valvuloplasty in pregnant patients with rheumatic mitral stenosis. Am J Cardiol. 2006;98(6):812–6. doi:10.1016/j.amjcard.2006.03.068.

Chen CR, Cheng TO. Percutaneous balloon mitral valvuloplasty by the Inoue technique: a multicenter study of 4832 patients in China. Am Heart J. 1995;129(6):1197–204. doi:10.1016/0002-8703(95)90404-2.

Palacios IF, Sanchez PL, Harrell LC, Weyman AE, Block PC. Which patients benefit from percutaneous mitral balloon valvuloplasty? Prevalvuloplasty and postvalvuloplasty variables that predict long-term outcome. Circulation. 2002;105(12):1465–71. doi:10.1161/01.cir.0000012143.27196.f4.

Rahman M, Ghafur S, Barman RN, Sarkar H, Basunia AZ, Islam MH, et al. Percutaneous trans-mitral commissurotomy (PTMC); procedural success and immediate results, an experience from tertiary care hospital in Northern division of Bangladesh. Univ Heart J. 2021;17(2):47–54.

Swaminathan GK, Sangareddi V. Clinical profile of patients undergoing percutaneous balloon mitral valvotomy and body surface area-based mitral valve area assessment. Int J Sci Res. 2020;9(1):1–3. doi:10.36106/ijsr/3233901.

Iung B, Cormier B, Ducimetiere P, Porte JM, Nallet O, Michel PL, et al. Immediate results of percutaneous mitral commissurotomy: a predictive model on a series of 1514 patients. Circulation. 1996;94(9):2124–30. doi:10.1161/01.cir.94.9.2124.

Sharma KH, Jain S, Shukla A, Bohora S, Roy B, Gandhi GD, et al. Patient profile and results of percutaneous transvenous mitral commissurotomy in mitral restenosis following prior PTMC vs surgical commissurotomy. Indian Heart J. 2014;66(2):164–8. doi:10.1016/j.ihj.2013.12.007.

Babu S, Kummaraganti R, Rajasekhar D, Vanajakshamma V, Kumar T. Assessment of mitral valve commissural morphology by transoesophageal echocardiography predicts outcome after balloon mitral valvotomy. Indian Heart J. 2013;65(3):269–75. doi:10.1016/j.ihj.2013.04.022.

Harrison JK, Wilson JS, Hearne SE, Bashore TM. Complications related to percutaneous transvenous mitral commissurotomy. Cathet Cardiovasc Diagn. 1994;Suppl 2:52–60.

NHLBI Balloon Valvuloplasty Registry. Complications and mortality of percutaneous balloon mitral commissurotomy: a report from the National Heart, Lung, and Blood Institute. Circulation. 1992;85(6):2014–24. doi:10.1161/01.cir.85.6.2014.

Kadiyala SR, Dhanse PR, SM. A case of acute myocardial infarction due to coronary artery embolism in patient with mitral stenosis following balloon mitral valvotomy. Indian Heart J. 2018;70(Suppl 3):S122. doi:10.1016/j.ihj.2018.10.371.